Maybe just maybe things are finally starting to happen.
Thank you Dr. Dalton

PR is attached... Enjoy



Leaders in Health Industry Join Forces to Address Mental Health and Substance Use Disorder

UNIVEC, Inc. and bioRemedies MD Align to Introduce products offering safe alternative to pain, anxiety and sleep disorders



Baltimore, MD (October 28, 2021) – Dr. David Dalton, CEO of UNIVEC, Inc. (OTC Markets UNVC) and Patrick Kelly, President of bioRemedies MD, LLC announced a breakthrough partnership to offer safe adjunct therapies for pain, anxiety and sleep disorders in the behavioral health setting.

Through a variety of proprietary formulated cannabinoid-based products developed by bioRemedies MD, Univec, Inc. is prepared to begin using these products in clinical behavioral health settings for out-patient treatment. bioRemedies MD specializes in Cannabinoid complementary and integrative products that have been in research and development at the University of Maryland Baltimore BioPark since 2016 after industrial hemp research was legitimized.

BioRemedies MD develops scientifically formulated cannabinoid products using FDA and Pharmaceutical processes, technology, and standards to ensure high quality, reproducible, and targeted formulations unlike anything in the market today. Their proprietary nanotechnology delivers cannabinoids efficiently and effectively, which is required for academic research and healthcare target markets and allows our commercial products to compete on quality and cost.

Univec, Inc. (OTC Markets UNVC) is an organization with a mission to change the way healthcare is delivered in America. Having recently announced the acquisition of several community based out-patient mental health centers to treat behavioral health. bioRemedies MD compliments Univec, Inc. (UNVC) principles--treating the patient as whole and applying “Total Wraparound” for patient, family and caregiver support.

Patrick Kelly, President of bioRemedies MD, LLC, remarked, “the time is now to bring these products to the community weary from substance use disorders and barriers to mental health treatment. This partnership with Univec, Inc. meets people where they are to help those suffering from pain, opioid misuse, anxiety and sleep disorders.

Univec, Inc. will make private label and bioRemedies MD products available through several distribution channels, including the recently acquired mental health centers. For additional information about access to treatment, contact

For more information call 410-340-5360 or email pat@bioremmd.com.


Read More: https://investorshangout.com/messages/view?id...z7AdbLyssB